Alerts will be sent to your verified email
Verify Email
CONCORD
|
Concord Drugs
|
Shanmuga Hospital
|
Godavari Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.38 % | 55.38 % | 14.02 % |
|
5yr Avg Net Profit Margin
|
1.88 % | 13.52 % | 2.93 % |
|
Price to Book
|
1.85 | 0.0 | 1.43 |
|
P/E
|
147.45 | 14.56 | 16.38 |
|
5yr Avg Cash Conversion Cycle
|
260.53 Days | -0.97 Days | 98.79 Days |
|
5yr Average Interest Coverage Ratio
|
1.8 | 103.51 | 2.53 |
|
5yr Avg ROCE
|
8.9 % | 68.42 % | 20.29 % |
|
5yr Avg Operating Profit Margin
|
9.09 % | 20.12 % | 7.21 % |
|
5 yr average Debt to Equity
|
0.55 | 0.39 | 1.32 |
|
5yr CAGR Net Profit
|
-21.63 % | -4.78 % | 22.65 % |
|
5yr Average Return on Assets
|
1.77 % | 33.09 % | 3.86 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
54.39 % | 72.11 % | 52.63 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.25 % |
|
Change in Promoter Holding (3 Yrs)
|
5.39 % | 0.16 % | -4.29 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Concord Drugs
|
Shanmuga Hospital
|
Godavari Drugs
|
|---|